Professionals | Aplastic Anemia & MDS International Foundation Return to top.


Introductory image: Patients at the Las Vegas conference



A Thread to Pull: Unraveling the Complexities of Myeloid Malignancies

CE Accreditation Period:  1/16/2023 – 1/16/2025
Topic(s): Related Bone Marrow Failure Diseases and Malignancies, Myelodysplastic Syndromes (MDS), Acute Myeloid Leukemia (AML)
Presenter: Sudipto Mukherjee, MD, MPH
Presenter: Bhumika Patel, MD
Presenter: Rodrigo Calado, MD, PhD
Presenter: Guillermo Sanz, MD, PhD
Presenter: Roland B. Walter, MD, PhD, MS
Presenter: Gabriela Hobbs, MD
Presenter: Craig S. Sauter, MD

This complimentary CME satellite symposium that provides an in-depth and up-to-date review of research related to biology, prognosis, natural history, and therapeutic management of patients with myeloid malignancies including PNH, MDS, AML, MPN and related myeloid malignancies. The overall goal of the program is to bring together leaders in disease research and clinical practice to explore solutions to improving the care of these patient populations.
Register to watch on-demand


Providing Equitable and Inclusive Care to Patients with Bone Marrow Failure Conditions  

Friday, November 4, 2022

Register Here

This free virtual symposium will provide updates on the most recent advances in the pathophysiology, diagnosis and clinical management of bone marrow failure diseases, including aplastic anemia, myelodysplastic syndromes (MDS), paroxysmal nocturnal hemoglobinuria (PNH), secondary acute myeloid leukemia (AML) and hematopoietic stem cell transplantation. Additionally, the program will address the current gaps in patient care for each of these diseases, such as clinical trial enrollment, reaching diverse patient populations, barriers to care, diagnostic challenges, genetic profiling, long term supportive care, and quality of life issues. Speakers will include representatives of innovative programs focusing on closing inequities and underserved patient populations. The patient voice will also be represented through patient panelists and patient survey responses. 

Target Audience:  Physicians, Fellows, APPs, NPs, nurses and social workers.  

Program Schedule

10:00 am                  Welcome and Introduction
                                 Mikkael Sekeres, MD, MS – Program Chair

10:05 – 10:30 am     Keynote Address:
                                Christopher Flowers, MD 
                                Chair and Professor at The University of Texas M.D. Anderson Cancer Center
                                Chair of the ASH Committee on Diversity, Equity and Inclusion

10:30 – 11:15 am    Myelodysplastic Syndromes and Secondary AML– 
                               Update on Diagnosis and Treatment
                               Low-Risk MDS – Namrata Chandhok, MD, 
                               Assistant Professor, Sylvester Comprehensive Cancer Center, University of Miami 
                               High-Risk MDS – Mikkael Sekeres, MD, MS
                               Professor, Sylvester Comprehensive Cancer Center, University of Miami 

11:15 – 11:45 am    Addressing the Gaps in Serving Patients with MDS - Panel Discussion                                         

                               Irum Khan, MD, MS, Associate Professor, University of Illinois
                               Leyla Shune, MD, Associate Professor, Hematologic Malignancies and Cellular Therapeutics
                               University of Kansas Cancer Center

11:45 – 12:30 pm    Aplastic Anemia and PNH – Update on Diagnosis and Treatment
                               Carlos DeCastro, MD – Professor, Duke University

12:30 – 1:00 pm     Addressing the Gaps in Serving Patients with Aplastic Anemia and PNH - Panel Discussion
                              Emma Groarke, MD, NHLBI Hematology Branch
                              Susie Lee, PA-C, Keck School of Medicine, University of Southern California
                              Debra O’Neal, MSW, Patient

1:15 – 1:45 pm      Hematopoietic Stem Cell Transplantation
                             Amy DeZern, MD, MPH – Johns Hopkins University 

1:45 – 2:15 pm     Addressing the Gaps in Serving Transplant Patients - Panel Discussion
                             Linda Burns, MD, Consultant and Senior Scientific Director, National Marrow Donor Program, CIBMTR
                             Nandita Khera, MD, MPH, Associate Professor, Mayo Clinic Arizona

2:15 – 3:00 pm     Supportive Care and Outpatient Management of Patients with Bone Marrow Failure Conditions - Panel Discussion
                             Jennifer Lotter PA, NHLBI Hematology Branch
                            Sandrine Niyongere, MD, Assistant Professor, University of Maryland 
                            Anastasia Marie Santiago, DNP, APRN, FNP-BC, AOCNP, Sylvester Comprehensive Cancer Center, University of Miami Hospital and Clinics

3:00 pm               Adjourn

Register Here


Leukemia, Lymphoma & Myeloma Congress

October 18-22, 2022
New York City, NY

Registration and Information HERE


Bone Marrow Failure Disease Scientific Symposium 2022

Register HERE to View on Demand

Listen to Neal Young, MD, and Richard Stone, MD, describe the value of attending the Eighth International Bone Marrow Failure Scientific Symposium on May 19-20, 2022.

This biennial Scientific Symposium is the only international forum focused solely on bone marrow failure diseases.  The world’s leading researchers on aplastic anemia, MDS, and PNH to discuss current areas of consensus and controversy, share recent research results, and identify the highest-priority directions for basic and clinical research to advance the field. 

The specific aims of this Symposium are to: 
• Foster collaborations among basic, clinical, and translational scientists and between scientists studying different diseases to help researchers better understand the diseases, form networks to advance their own research, and identify new approaches to transform findings into treatments
• Increase participants’ understanding of the molecular events that drive these diseases and the responses to treatment required to define at-risk populations and improve current therapies
• Develop recommendations for advancing basic, clinical, and translational research in bone marrow failure diseases
• Provide important opportunities to train and encourage young investigators to pursue a career in bone marrow failure disease research

Symposium Co-Chairs:  Richard Stone, MD, Dana-Farber Cancer Institute and Neal Young, MD, NHLBI

Symposium sessions include:

Thursday, May 19
• Genetics and Genomics of Bone Marrow Failure
• Somatic Mutations in Benign Diseases:  AA, PNH, VEXAS Syndrome
• Advances in Paroxysmal Nocturnal Hemoglobinuria
• Transplantation for Bone Marrow Failure
• Non-transplant Therapies for Marrow Failure

Friday, May 20
• MDS and Secondary AML Pathophysiology
• MDS Tools for Prognosis:  Regaining Consensus
• Treatments for MDS and Secondary AML

Register HERE to View on Demand

View session leaders’ summary interviews Here 

The symposium is supported by educational grants from Novartis, Alexion, Apellis, Biocryst, Regeneron, and Geron.


Share with